Astract. Staphylococcal a-toxin is known to damage mammalian cell membranes. Studies of erythrocytes indicate that the native toxin generates a discrete transmembrane channel with an effective diameter of 2-3 nm. (Fiissle, R., S. Bhakdi, A. Szeigoleit, J. TranumJensen, T. Kranz, and H. J. Wellensiek. 1981. J. Cell BioL 91:83-94.) In isolated rabbit lungs, perfused with recirculating blood-and plasma-free perfusion fluid, the mediation of a toxin-provoked vascular pressor response by the triggering of the arachidonic acid cascade and its dependence on extracellular calcium were investigated. Dose-dependent pulmonary artery pressor responses were elicited by the injection of 0.5-5 jg staphylococcal a-toxin into the pulmonary artery. The pressor responses were completely abolished by preincubation of the toxin with neutralizing antibodies or by preformation of atoxin hexamers in vitro. They were accompanied by the release of the arachidonic acid metabolites thromboxane B2 and 6-keto-prostaglandin Fl, ( release of potassium, but not lactatedehydrogenase into the medium. Calcium depletion of the intravascular space did not suppress the toxin-dependent potassium release but did abrogate the pressor response and the release of the arachidonic acid metabolites. When calcium was reintroduced into the circulation without the application of a second toxin stimulus, marked pressor responses paralleled by the release of arachidonic acid metabolites occurred.
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The conclusion drawn from these studies is that staphylococcal a-toxin provokes pulmonary vascular hypertension which is apparently mediated by thromboxane A2 formation, which surpasses the biological effect of the simultaneously formed prostaglandin 12. The triggering of the arachidonic acid cascade is strictly dependent on extracellular calcium and may be mediated by a nonphysiological calcium bypass through transmembrane toxin channels with subsequent stimulation of phospholipase activity.
Introduction
Staphylococcal a-toxin has been considered one of the essential factors associated with staphylococcal pathogenicity (1) (2) (3) . Cytotoxic activities, and probably also the lethal effect of atoxin, appear to be linked to its membrane-damaging action (4) . Studies in the erythrocyte membrane model indicate that the native toxin oligomerizes to form a hexameric annular complex which, through its partial embedment within the lipid bilayer, generates a discrete transmembrane channel (5) . When toxin is injected intravenously into rabbits, the most is recovered from the kidneys and lungs (6) .
With isolated rabbit lungs as a model system, a variety of stimuli have recently been shown to provoke a constriction of the pulmonary vascular bed via activation of phospholipase, arachidonic acid release from membrane phospholipids, and A2 (TxA2)' (7) (8) (9) (10) . In this communication we report that atoxin provokes a dose-dependent pressor response which is apparently mediated by thromboxane formation in the pulmonary vascular bed. Thromboxane evidently surpasses the biological effect of the simultaneously formed prostaglandin I2 (PGI2). Pressor response and mediator release are strictly dependent on extracellular calcium and may initially be triggered by calcium flux through transmembrane toxin channels.
Methods
The investigations were performed with a model of isolated rabbit lungs which has been previously described (8) . Briefly, lungs were removed from deeply anesthetized rabbits (body weight 2.2-2.6 kg) without interruption of ventilation and perfusion, and suspended freely from a force transducer in a chamber warmed to 381C. They were ventilated (frequency, 45 strokes/min; tidal volume, 30 ml) with 4% CO2, 17% 02, and 79% N2 and perfused with (calcium containing) Krebs Henseleit hydroxyethylamylopectine (200,000 mol wt, 4% wt/ vol) buffer (KHHB) in a recirculating system (circulating volume, 125 ml) with a pulsatile constant flow of 200 ml/min. By the alternate use of two separate perfusion systems it was possible to perform numerous perfusion phases in the same isolated lung, each with fresh perfusion fluid with or without the addition of stimuli and/or inhibitors. The physical parameters-perfusion pressure, ventilation pressure, and the weight of the isolated lung-were registered continuously by pressure transducers and a force transducer. The reproducibility of these physical measurements showed a standard deviation of <3%. Only those lungs were selected that after a steady state period of at least 45 min were completely blanched and showed no spontaneous edema formation or changes of ventilation or perfusion pressure. Light microscopical examination of these lungs revealed no adherence of erythrocytes, platelets, or leucocytes to the vascular wall. a-Toxin, dissolved in 20 M1l saline, was injected directly into the pulmonary artery (indicated by arrows in Figs 1, 2 , and 4). Inhibitors were added to the perfusion fluid at the stated final concentrations before recirculation. Purified atoxin and a-toxin antibodies were prepared as previously described (1) . Thromboxane B2 (TxB2) and 6-keto-prostaglandin Fla (6-ketoPGFia), the stable products of TxA2 and PGI2, were measured radioimmunologically with kits commercially available from New England Nuclear (Boston, MA). Lactatedehydrogenase (LDH) was measured photometrically and potassium was measured by flame photometry. TMB After the onset of the pressor response, a-toxin caused an increase in lung weight and, after the edema formation, an increase in ventilation pressure, neither of which has been further evaluated in this study.
Release of TxB2 and 6-keto-PGF,, into the perfusion fluid after stimulation with a-toxin Compared with 15-min control phases (TxB2, 65±21 pg/ml; 6-keto-PGF1,, 182±80 pg/ml; n = 18), the concentrations of these arachidonic acid metabolites were markedly higher after stimulation with 2.5 MIg a-toxin (TxB2, 256±215 pg/ml, P < 0.05; 6-keto-PGFIa, 880±455 pg/ml, P < 0.001; n = 7) and with 5 Mg toxin ( Fig. 2) (TxB2, 1,092±764 pg/ml, P < 0.001; 6-keto-PGFIa, 2,240±1,380 pg/ml, P < 0.001; n = 7).2 After the application of 2.5 Mg a-toxin, the arachidonic acid metabolites continued to be released in the absence of a second toxin stimulus (TxB2, 239±177 pg/ml, P < 0.001; 6-ketoPGFia, 1,020±519 pg/ml, P < 0.001; n = 4; measured in the subsequent 15-min rinsing phase).
2. As a rule, the concentrations of TxB2 and 6-keto-PGF,6 in the recirculating perfusion fluid were determined from a sample taken 15 min after application of the stimulus. However, experiments were stopped when the edema formation exceeded 15 g weight gain. Thus, after 5 Mg a-toxin, the period between stimulus application and removal of sample for arachidonic acid metabolite determination varied between 7.5 and 15 min. 3). OKY-046 (thromboxane synthetase inhibitor) caused a dose dependent and parallel inhibition of both the pressor response and TxB2 release, whereas the release of 6-ketoPGFia even increased (Fig. 3 ). Both inhibitors as well as imidazole (thromboxane synthetase inhibitor) blocked the pressor responses after the administration of a-toxin to the same extent as the pressor responses after the direct application of arachidonic acid or after stimulation of the arachidonic acid cascade by the known calcium-ionophore A 23187 (8, 1 1) (Fig. 4 , Table I ). Phospholipase inhibition. The pressor response after the administration of 5 Mug a-toxin was markedly reduced by 100 MM mepacrine. This concentration also inhibited the pressor response after stimulation with the ionophore A 23187 but not after direct application of arachidonic acid (Fig. 4 , Table I ).
Inhibitors of intracellular calcium and of calcium-calmodulin. W 7 (calmodulin inhibitor), trifluoperazine (calciumcalmodulin inhibitor), and TMB 8 (intracellular calcium antagonist) were used in concentrations that block A 23187-induced pressor responses but not the response that follows direct application of arachidonic acid. All substances markedly blocked the pressor response after stimulation with 5 ,ug atoxin. In addition, the remaining pressor response of <10-25% after the application of the different inhibitors appeared after a latent period of 5.1 ± 1.9 min after injection of 5 ,ug atoxin (control without inhibitor, 2.3±0.9 min; P < 0.001). The postrinsing pressor responses provoked by the lower a-toxin dose of 2.5 Mg a-toxin were completely suppressed by all inhibitors in the above given concentrations (n = 3 for each substance; n = 1 for TMB 8).3
3. Due to a lack of material only a few experiments could be performed with TMB 8: because a concentration of 100 MM reduced the pressor response provoked by A 23187 by only 50%, the reported high concentration of 500 uM was selected (27-31). (Table II) . In contrast, the pressure peaks after A 23187 and bradykinin, both of which depend on calcium shift and arachidonic acid release (7, 8) , were markedly blocked and could barely be restored by a fourfold increase in dosage (<30%). The behavior of a-toxin mimicked the latter group (Table II, 5 and 20 ug toxin). In addition, there was no postrinsing pressor response after 2.5 ,ug toxin was added to calcium-free medium (n = 5). The described mode of calcium depletion did not completely suppress the reaction chain evoked by the toxin. This, however, could be achieved by the addition of EGTA (5 mM) to calcium-free KHHB (n = 3; example given in Fig. 2 These two stimuli provoked steep pressure peaks, which could be repeated several times within the same lung (8, 9) . § For a-toxin the maximum rate of pressure increase (mmHg/min) is given for the control group and for each inhibitor group. 1 l and ¶ indicate values taken from previously published investigations (references 8 and 9, respectively).
artery pressor response in a concentration as low as 0.04 jug/ ml perfusion fluid, and that this response occurs in the absence of plasma and circulating cells. It is apparently mediated by stimulation of the pulmonary vascular arachidonic acid cascade, and among the different arachidonic acid metabolites the cyclooxygenase product TxA2 appears to be primarily responsible: the reaction is accompanied by the release of the stable TxA2 metabolite TxB2; it is dose dependent and, in higher concentrations, almost completely suppressed by inhibitors of cyclooxygenase (indomethacin [22] ) and thromboxane synthetase (OKY-046 [23] and imidazole [24] ). TxA2 mimicking substance U-466 19 (12-14), used in the same range of concentration in which TxB2 is detected in the perfusion fluid after a-toxin stimulation, can provoke an acute pressure rise in the isolated lung model. The vasoconstrictive effect of TxA2 apparently surpasses the biological effect of PGI2, which is known to cause pulmonary vasodilatation (8) and which is released in the same or even in higher concentrations as thromboxane. This is in accordance with various other pathophysiological stimuli provoking pulmonary artery pressor responses mediated by thromboxane in isolated rabbit lungs, e.g., bradykinin and kallidin (9), fibrinmonomers (25) , and phosphatidic acid (26) .
In contrast to these stimuli, the calcium-ionophore A 23187 (8) , and toxins such as eledoisin (9) and mellitin (Seeger, W., unpublished results), the pressor response provoked by 0.04
,gg/ml a-toxin is not reversible by rinsing the lungs with fresh perfusion fluid. The cellular origin of the arachidonic acid metabolites has not been established in the isolated lung model. Endothelial cells, however, are very likely candidates for the noted PGI2 release, since this arachidonic acid metabolite is generated by a-toxin-incubated pulmonary endothelial cells in vitro. 4 The simultaneous formation of arachidonic acid cyclooxygenase products with antagonistic effects, different kinetics of formation and turnover, and possibly different cellular sources may explain why subthreshold dosages of atoxin provoked pressor responses not immediately, in the injection phase, but in the subsequent rinsing phase. Triggering ofthe arachidonic acid cascade is strictly dependent on extracellular calcium and may be mediated by calciumcalmodulin. Calcium depletion of the vascular space markedly suppressed the toxin-induced pressor response. The addition of EGTA to the perfusion fluid rendered the lungs refractory to the toxin stimulus, and no arachidonic acid metabolites were released. In all of these experiments, potassium effilux still occurred. This was expected since toxin-mediated membrane damage is not a calcium-dependent process (1) . The results were very striking when calcium was offered again to such toxin-treated calcium-depleted lungs without a second toxin stimulus; fulminant pressor responses without any latent period ensued, paralleled in each case by an instantaneous release of the arachidonic acid metabolites TxB2 and 6-ketoPGFia into the perfusion fluid (Fig. 2) . In the studies with isolated endothelial cells, a dose-dependent uptake of 45- calcium after a-toxin incubation could be shown. 4 The necessity of an increase of intracellular calcium to trigger the arachidonic acid cascade after a-toxin stimulation in the isolated lung model was supported by the inhibitory effect of TMB 8, supposedly an antagonist of intracellular calcium (27-31).
Since the cyclooxygenase, thromboxane synthetase, and PGI2 synthetase steps are apparently calcium independent (32) (33) (34) , it remains the release of the precursor arachidonic acid that must be inhibited by extracellular calcium depletion and by the application of TMB 8. Phospholipase (A2/C)-dependent release of arachidonic acid from cell membranes appears to be the general ratelimiting step in arachidonic acid metabolism (35, 36) . In (1) . Studies with isolated pulmonary endothelial cells showed compatible molecular sieving data with a restricted diffusion of large molecules (molecular weight > 5,000) and a passive uptake of 45-calcium after a-toxin incubation.4 aToxin also caused the selective release of potassium, but not of LDH, in the isolated lung model. This differential release was characteristic: the calcium-ionophore A 23187 induced the release of neither, whereas the Pseudomonas aeruginosa cytotoxin released both markers (15). The potassium release was not a secondary phenomenon induced by calcium flux or arachidonic acid metabolites since it also took place in the absence of calcium and without the release of arachidonic acid metabolites. Thus, there is cause to assume that a-toxin forms transmembrane pores also in the isolated lung model. This idea is corroborated by the finding that the reintroduction of calcium into the circulation after previous toxin application in absence of calcium is followed by an immediate and more than compensatory pressure rise and by mediator release without any latent period. As expected, the injection of preformed toxin hexamers unable to attack the membrane (16) or of a-toxin preincubated with neutralizing antibodies provoked neither potassium release nor the pressor response.
Conclusion. Staphylococcal a-toxin causes a pulmonary artery pressor response in the absence of plasma and circulating cells, which is irreversible in higher concentrations. It appears to be primarily mediated by the arachidonic acid cyclooxygenase product TxA2 which surpasses the biological effect of the simultaneously formed PGI2. The triggering of the arachidonic acid cascade is strictly dependent on extracellular calcium and is markedly reduced by inhibitors of calcium-calmodulin complex and phospholipase. The selective release of potassium, but not of LDH, is compatible with the notion that also in the isolated lung model, a-toxin forms transmembrane pores. Calcium flux through these nonphysiological bypass channels according to the steep gradient of extracellular-to-intracellular calcium concentration may be the primary signal that triggers the arachidonic acid cascade below the threshold of overt cell damage.
